191 related articles for article (PubMed ID: 31260748)
1. Incidence of Leiomyosarcoma at Surgery for Presumed Uterine Myomas in Different Age Groups.
Rey Valzacchi GM; Rosas P; Uzal M; Gil SJ; Viglierchio VT
J Minim Invasive Gynecol; 2020; 27(4):926-929. PubMed ID: 31260748
[TBL] [Abstract][Full Text] [Related]
2. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas.
Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG
J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458
[TBL] [Abstract][Full Text] [Related]
4. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
[TBL] [Abstract][Full Text] [Related]
5. Incidence of occult leiomyosarcoma in presumed morcellation cases: a database study.
Rodriguez AM; Zeybek B; Asoglu MR; Sak ME; Tan A; Borahay MA; Kilic GS
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():31-5. PubMed ID: 26699101
[TBL] [Abstract][Full Text] [Related]
6. Incidence of occult uterine sarcoma and other unexpected pathologies in patients having surgery for presumed myomas: A retrospective observational study.
Mühlenbrock MV; Navarrete-Rey P; Kovoor E; Guzman-Rojas R; Troncoso F; Miranda-Mendoza I
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):101992. PubMed ID: 33217603
[TBL] [Abstract][Full Text] [Related]
7. Occult uterine leiomyosarcoma in women undergoing abdominal and minimally invasive surgeries for myomas.
Ludwin A; Gawron I; Pityński K
Ginekol Pol; 2018; 89(10):546-552. PubMed ID: 30393842
[TBL] [Abstract][Full Text] [Related]
8. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
[TBL] [Abstract][Full Text] [Related]
9. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
[TBL] [Abstract][Full Text] [Related]
10. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications.
Lange S; Pluchino N; Fehlmann A; Marci R; Boukrid M; Jazia IB; Petignat P; Dubuisson J
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():239-244. PubMed ID: 28743407
[TBL] [Abstract][Full Text] [Related]
12. Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy.
Surace A; Baù MG; Privitera S; Botta G; Danese S; Plazzotta C; Mitidieri M; Picardo E
Int J Gynaecol Obstet; 2022 Feb; 156(2):236-239. PubMed ID: 33834486
[TBL] [Abstract][Full Text] [Related]
13. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
Zullo F; Venturella R; Raffone A; Saccone G
Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
[TBL] [Abstract][Full Text] [Related]
14. ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas.
Obstet Gynecol; 2019 Mar; 133(3):604-605. PubMed ID: 30801469
[TBL] [Abstract][Full Text] [Related]
15. Uterine Morcellation for Presumed Leiomyomas: ACOG Committee Opinion, Number 822.
Obstet Gynecol; 2021 Mar; 137(3):e63-e74. PubMed ID: 33595252
[TBL] [Abstract][Full Text] [Related]
16. Survey among ESGE members on leiomyosarcoma morcellation incidence.
Tanos V; Brölmann H; DeWilde RL; O'Donovan P; Symeonidou E; Campo R
Gynecol Surg; 2017; 14(1):25. PubMed ID: 29238287
[TBL] [Abstract][Full Text] [Related]
17. No. 371-Morcellation During Gynaecologic Surgery: Its Uses, Complications, and Risks of Unsuspected Malignancy.
Murji A; Scott S; Singh SS; Bougie O; Leyland N; Laberge PY; Vilos GA
J Obstet Gynaecol Can; 2019 Jan; 41(1):116-126. PubMed ID: 30580824
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic Power Morcellation: Techniques to Avoid Tumoral Spread.
Zapardiel I; Boria F; Halaska MJ; De Santiago J
J Minim Invasive Gynecol; 2021 Aug; 28(8):1442-1443. PubMed ID: 32961359
[TBL] [Abstract][Full Text] [Related]
19. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
Cui RR; Wright JD
Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
[TBL] [Abstract][Full Text] [Related]
20. Incidence of unexpected leiomyosarcoma in a Turkish province: a retrospective multi-centre study in a low income setting.
Taşdemir Ü; Ceran MU; Önder Dirican A; Akar S; Çelik Ç; Energin H; Görkemli H; Mammadova N; Çolak E; Ayhan A
J Obstet Gynaecol; 2022 Aug; 42(6):2208-2212. PubMed ID: 35253591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]